Trade Summary

3 days ago, McKee Amy E, serving as Dir at Biocryst Pharmaceuticals Inc (BCRX), sold 11,180 shares at $8.97 per share, for a total transaction value of $100,285.00. Following this transaction, McKee Amy E now holds 31,252 shares of BCRX.

This sale represents a 26.00% decrease in McKee Amy E's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, May 18, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, May 19, 2026 at 4:07 PM ET, 1 day after the trade was made.

Biocryst Pharmaceuticals Inc operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.